We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current GNRO market cap is 2.29M. The company's latest EPS is EUR and P/E is N/A.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.99M | -7.46M | -6.37M | -11.23M | -14.36M |
| Net Income | -9.46M | -8.96M | -6.82M | -12.2M | -14.76M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 9.4M | 10.51M | 12.54M | 11.47M | 6.36M |
| Total Liabilities | 14.61M | 5M | 7.7M | 10.01M | 20.14M |
| Total Equity | -5.21M | 5.52M | 4.85M | 1.46M | -13.78M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -9.89M | -7.17M | -6.77M | -13.06M | N/A |
| Investing | -47k | -22k | -43k | -50k | N/A |
| Financing | 6.94M | 8.15M | 5.38M | 13.1M | N/A |
| Market Cap | 2.29M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 29.76M |
| Average Volume (1 week) | 21.24k |
| Average Volume (1 Month) | 25.57k |
| 52 Week Change | -92.75% |
| 52 Week High | 2.35 |
| 52 Week Low | 0.0558 |
| Spread (Intraday) | 0.02 (21.87%) |
| Company Name | GeNeuro SA |
| Address |
18 chemin des aulx geneva 1228 |
| Website | https://www.geneuro.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
